Target intelligence / Profile preview

3'-untranslated region microRNA response element (3'-UTR MRE)

Target
3'-UTR MRE
Molecular classification
Nucleic acid, Regulatory element, RNA sequence
01

Overview

3'-untranslated region microRNA response elements (3'-UTR MREs) are specific nucleotide sequences located within the 3' untranslated region of messenger RNA (mRNA) that are recognized and bound by microRNAs (miRNAs). These elements are fundamental to post-transcriptional gene regulation, as the binding of a miRNA-induced silencing complex (miRISC) to an MRE typically leads to the degradation of the mRNA transcript or the inhibition of its translation into protein (Bartel, 2009, Cell). In various pathologies, including cancer and cardiovascular diseases, mutations within these MREs or changes in miRNA availability can lead to the escape of oncogenes from regulation or the inappropriate silencing of tumor suppressors (Ryan et al., 2010, Nature Reviews Cancer). Therapeutic strategies targeting MREs include the use of antisense oligonucleotides (ASOs) known as target site blockers (TSBs), which physically occupy the MRE to prevent miRNA binding and thereby restore protein expression (Baumann and Winkler, 2014, Frontiers in Bioengineering and Biotechnology). Additionally, miRNA mimics can be introduced to target these elements when endogenous miRNA levels are insufficient. The specificity of the MRE-miRNA interaction makes these sites attractive targets for precision medicine, although challenges remain regarding the delivery of nucleic acid therapeutics and potential off-target effects on other mRNAs containing similar sequences.

Other names
miRNA binding siteMicroRNA response elementMRE3'-UTR regulatory elementSeed match site
02

Mechanism of action

Targeting 3'-UTR MREs involves either the use of miRNA mimics to enhance the natural repressive effect on a target mRNA or the use of antisense oligonucleotides (ASOs), such as target site blockers (TSBs), to sterically hinder the binding of endogenous miRNAs, thereby preventing gene silencing and increasing protein production.

03

Biological functions

Post-transcriptional gene regulationmRNA degradationTranslational inhibitionGene silencing
04

Disease associations

CancerCardiovascular diseaseNeurodegenerative diseaseViral infectionMetabolic disorder
05

Safety considerations

Off-target hybridizationInnate immune activationSaturation of RNAi machineryTissue-specific delivery challenges
06

Interacting drugs

Miravirsen

6 more in the full profile.

07

Biomarkers

Target mRNA expression levelsTarget protein expression levelsmiRNA expression profiles

Beyond the preview

Go deeper on 3'-untranslated region microRNA response element (3'-UTR MRE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3'-untranslated region microRNA response element (3'-UTR MRE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call